Skip to main content
International Journal of Clinical and Experimental Medicine logoLink to International Journal of Clinical and Experimental Medicine
. 2015 Jun 15;8(6):9890–9896.

KCNA5 gene polymorphism associate with idiopathic atrial fibrillation

Li Tian 1, Gang Liu 1, Le Wang 1, Mingqi Zheng 1, Yongjun Li 2
PMCID: PMC4538049  PMID: 26309673

Abstract

Objective: To investigate the correlation between KCNA5 single nucleotide polymorphism (SNP) and idiopathic atrial fibrillation (IAF). Methods: A case-control study was conducted, including 282 cases of IAF patients and 300 cases of age and sex-matched normal controls; gene sequencing method was used to detect the distribution of KCNA5 SNP (rs3741930 and rs1056468) in the two groups. The IAF patients were divided into two groups based on the different genotypes of rs1056468 and rs3741930; differences in clinical parameters between the two groups of patients were compared. Results: For rs3741930, the CC, CT and TT genotype frequencies in the IAF group were 16.7%, 50.0%, and 33.3% respectively; C allele frequency in IAF group was 41.7%; in the normal control group, those were 10.0%, 49.3%, 40.7% and 34.7% respectively; CC genotype frequency and C allele frequency in IAF group were significantly higher compared with the control group (P=0.019, P=0.014). For rs1056468, the AA, AT and TT genotype frequencies in the IAF group were 44.3%, 48.6%, and 7.1% respectively; in 300 cases of normal controls, those were 38.7%, 50.7%, and 10.6% respectively; A allele frequency in IAF group was 68.6 %, and it was 64.0% in normal controls. There were no significant differences in genotype and allele frequencies between control and IAF groups (P>0.05). In IAF group, among different genotypes of rs1741930 and rs1056468, there were no significant differences in age, SBP, DBP, HR, LAD and LVEF (P>0.05). While the BMI in CC and CC+TT groups of rs3741930 locus were 26.9±2.3 Kg/m2 and 24.8±2.5 Kg/m2 respectively. There were statistical differences between the two groups (P=0.019). BMI in AA and AA+TT groups of rs1056468 locus were 24.9±2.7 Kg/m2 and 26.4±2.4 Kg/m2 respectively; There was statistically significant significance between the two groups (P=0.014). Conclusion: The single nucleotide polymorphism rs3741930 locus in KCNA5 gene was related to the risk of IAF; the population carrying C allele was more susceptible to IAF; the polymorphic loci, rs3741930 and rs1056468, were correlated with the BMI of IAF patients.

Keywords: Idiopathic atrial fibrillation, KCNA5, SNPs

Introduction

Atrial Fibrillation (AF) is a common clinical tachyarrhythmia. According to the AF guideline proposed by European Society of Cardiology (ESC) in 2010 [1], the prevalence of AF in general population is 1-2%; ZHOU et al [2] found that in the Chinese population, the incidence of AF is around 0.77%, which is higher in men than women; the incidence was positively correlated with age, and in elderly population older than 80 years, the incidence rate is up to 7.5%.

The advanced age, male gender, hypertension, obesity, coronary heart disease, myocardial infarction, valvular heart disease and hyperthyroidism were the traditional risk factors for AF [3-6]. However, there are some younger AF patients who have not these traditional risk factors such as structural heart disease, high blood pressure, valvular heart disease, hyperthyroidism and myocardial infarction. This kind of AF is named idiopathic atrial fibrillation (IAF) [7]. IAF patients often have a familial aggregation, and its pathogenesis may be related to genetic factors [8].

Framingham study showed that if there is at least one parent with AF, the risk of AF in offspring will significantly increase (OR=1.85, 95% CI 1.12-3.06, P=0.02). If the first-onset-age of farther (mother) was younger than 75 years, the risk will be higher (OR=3.23, 95% CI: 1.87-5.58, P<0.001) [9]. Arnar et al [10] reported that, when there were AF patients in parents and siblings, the relative risk of AF was 1.77. And when the AF onset-age of parents and siblings was younger than 60 years, the relative risk increased to 4.67 times, which is similar to Framingham study. In 2009, a Danish researcher found [11] that the probability of simultaneous AF in identical twins (n=356) was significantly higher than that in fraternal twins (n=781) (22.0% vs. 11.6%, P<0.0001).

In subsequent studies, Chinese scholar Chen [12] conducted a microsatellite and genome-wide association study for a Chinese familial atrial fibrillation (FAF) family in 2003, and found that KCNQ1 gene mutation was related with AF generation and maintenance; the gene encodes a subunit of slow delayed rectifier potassium current (Iks) channel in cardiomyocytes. By sequencing they found that the adenine nucleotide in the 418 locus of the gene was replaced by guanine nucleotide (A>G), leading to the replacement of 140th Serine by Glycine (S140G) in the encoded Iks channel protein. The mutation was only found in patients with AF in this family, and none of the mutation was screened in a wider range of healthy control population. Further research found that this mutation can enhance Iks potassium current, shorten action potential duration and effective refractory phase of atrial myocytes, and easy the atrium reentry to induce AF. Yang et al [13] found that in 2004, KCNE2 mutations located in the 21 q22.1 region of human chromosome 21 were associated with AF; the gene encodes the β subunit of slow delayed rectifier potassium current (Iks) channel in cardiac myocytes; its mechanism of inducing AF is similar to S140G. Otway et al [14] found that in 2005, KCNQl R14C missense mutation was related with AF. R14C mutation in this gene can increase Iks channel current under hypotonic state, and faster the activation speed, and slow deactivation rate. The results confirmed that other factors could interact with genetic mutations to co-induce AF.

Since Brugada [15] found the first AF locus 10q22-q24 region in 1997, so far more than ten disease-causing gene mutations which can induce the IAF and FAF have been found, such as KCNJ2, KCNH2, ABCC9, KCNN3, NPPA, KCNQI, KCNSA, and CYP11B [16-22]. Speeding delayed rectifier potassium current (IKur) is a potassium ion channel current only existing in atrial myocytes, playing an important role in the repolarization and action potential duration of atrial myocytes; its molecular basis is Kv 1.5 potassium channel; KCNA5 gene encodes the pore section of the channel; KCNA5 genetic mutation can cause changes in Ikur, thereby inducing IAF. Therefore, this study selected IAF patients as subjects to explore the correlation between KCNA5 gene single nucleotide polymorphism (SNP) and the IAF.

Subjects and methods

Subjects

In this study, 282 patients with IAF admitted in the First Hospital of Hebei Medical University and the Second Hospital of Hebei Medical University were collected from May 2008 to November 2014.

Inclusion criteria

The included patients must meet to 1) ECG suggesting AF; 2) AF signs existing: the intensity of first heart sound varied, absolutely irregular heartbeat, and pulse shortage; 3) presence of AF symptoms with palpitation, shortness of breath, or irregular heartbeat, etc. or without related symptoms.

Exclusion criteria

The patients will be excluded from this study if meet to the following factors: 1) with coronary heart disease, cardiomyopathy, pericarditis, hypertension, hyperthyroidism, structural heart disease and other traditional risk factors and 2) age of onset >60 years.

All included patients underwent comprehensive and systemic medical history review and physical examination, and the electrocardiogram, echocardiogram, blood count, blood chemistry and other laboratory examinations were carried out. 300 cases of age and sex-matched healthy individuals were identified as the control group. In both case and control groups, 5 ml peripheral blood from each patient were drawn into anticoagulant tubes containing EDTA, and placed in -80°C refrigerator for DNA extraction. The study was approved by the ethic committee of Tongji Hospital, and all patients and controls have signed the informed consent.

Methods

Polymorphic loci selection

KCNA5 gene is located on the 12p13 region of human chromosome 12 [23,24]. We selected two SNPs (rs3741930 and rs1056468) according to human genome database on HapMap (http://hapmap.ncbi.nlm.nih.gov//). rs3741930 (C>T) is located in 5 ‘Untranslated Region (5’-UTR) and rs1056468 (A>T) is located in 3’Untranslated Regions (3’-UTR).

Genomic DNA extraction

Genomic DNA from the whole blood cells was extracted using a QIAamp Blood kit (Qiagen, Hilden, Germany), following the manufacturer’s instructions. DNA concentration and purity of each sample were measured by ultraviolet spectrophotometer (Eppendorf, Hamburg, Germany). DNA samples were routinely stored at -20°C.

Genotyping

Analysis of rs3741930 and rs1056468 were performed using TaqMan SNP genotyping assay allelic discrimination method (Applied Biosystems) as previously described [25,26]. The average genotype completeness was 98% for the patient and control subject samples. The accuracy was >99% according to duplicate genotyping of 10% of all samples.

Statistical analysis

All data were processed using SPSS 17.0 statistical software (SPSS, Chicago, IL, USA). Hardy-Weinberg equilibrium (HWE) were analyzed using χ2 test; and the frequency distributions of KCNA5 SNPs in the IAF and control groups were compared using χ2 test. In order to assess the impact of KCNA5 SNPs on IAF progression, the patients were divided into two groups (wild-type and mutant-type) based on different genotypes; the significant differences in clinical indicators were analyzed between the two groups of patients. χ2 test was used to compare percentages and ratios; t test was used to compare the mean index. P≤0.05 was considered significant.

Results

Characteristics of participants

IAF patients included 221 males and 61 females which were in line with the typically high incidence of AF in males. The mean age was 46.12±9.11 years (from 18 years old to 60 years old). In normal control group, there were 226 males and 74 females; the mean age was 47.12±8.43 years (ranging from 30 years old to 60 years old). There was no significant difference between the two groups both in age and sex (P>0.05).

Genotype and allele frequency distribution of rs3741930

As shown in Table 1, the genotypes distribution of rs3741930 both in IAF group and control group were in line with H-WE. The CC, CT and TT genotype frequencies in the IAF group were 16.7%, 50.0%, and 33.3% respectively; C allele frequency in IAF group was 41.7%; in the normal control group, those were 10.0%, 49.3%, 40.7% and 34.7% respectively; CC genotype frequency and C allele frequency in IAF group were significantly higher compared with the control group (P=0.019, P=0.014).

Table 1.

Distribution of genotype and allele frequency of rs3741930 in IAF and control group

SNPs IAF group Control group P value OR (95% CI)

(n=282) (n=300)
rs371930
    Genotype CC 47 (16.7%) 30 (10.0%) 0.019 1.800 (1.102~2.938)
CT 141 (50.0%) 148 (49.3%) 0.813 1.027 (0.741~1.422)
TT 94 (33.3%) 122 (40.7%) 0.068 0.729 (0.520~1.023)
    Allele C 235 (41.7%) 208 (34.7%) 0.014 1.346 (1.062~1.706)
T 329 (58.3%) 392 (65.3%)

OR: Odds ratio, CI: Credible intervals.

Genotype and allele frequency distribution of KCNA5 rs1056468

As shown in Table 2, rs1056468 genotypes frequency distribution was also in line with H-WE. The AA, AT and TT genotype frequencies in the IAF group were 44.3%, 48.6%, and 7.1% respectively; in 300 cases of normal controls, those were 38.7%, 50.7%, and 10.6% respectively; A allele frequency in IAF group was 68.6 %, and it was 64.0% in normal controls. There were no significant differences in genotype and allele frequencies between control and IAF groups (P>0.05).

Table 2.

Distribution of genotype and allele frequency of rs3741930 in IAF and control group

SNPs IAF group Control group P value OR (95% CI)

(n=282) (n=300)
rs1065486
    Genotype AA 125 (44.3%) 116 (38.7%) 0.166 1.263 (0.907~1.357)
AT 137 (48.6%) 152 (50.7%) 0.615 0.920 (0.664~1.274)
TT 20 (7.1%) 32 (10.6%) 0.133 0.639 (0.356~1.126)
    Allele A 387 (68.6%) 384 (64.0%) 0.095 1.229 (0.964~1.569)
T 177 (31.4%) 216 (36.0%)

OR: Odds ratio, CI: Credible intervals.

Comparisons of clinical data among different genotypes in IAF group

The relationships among various clinical parameters in patients with different genotypes of rs3741930 and rs1056468 were analyzed respectively (Table 3). The results showed that for the two loci, there was no significant correlation among age, systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), left atrium diameter (LAD), left ventricular ejection fraction (LVEF) and other clinical indicators (P>0.05). While the BMI in CC and CC+TT groups of rs3741930 locus were 26.9±2.3 Kg/m2 and 24.8±2.5 Kg/m2 respectively. There were statistical differences between the two groups (P=0.019). BMI in AA and AA+TT groups of rs1056468 locus were 24.9±2.7 Kg/m2 and 26.4±2.4 Kg/m2 respectively; There was statistically significant significance between the two groups (P=0.014).

Table 3.

The characteristics of included participants among different genotypes

Indices rs3741930 rs1056468

CC CT+TT P values AA AT+TT P values
Age (Year) 46.6±6.4 46.7±7.1 0.443 46. 8±7.4 47.1±7.0 0.490
BMI (Kg/m2) 26.9±2.3 24.8±2.5 0.019 24.9±2.7 26.4±2.4 0.014
SBP (mmHg) 122.1±11.3 118.1±12.3 0.305 118.3±11.8 121.4±12.4 0.132
DBP (mmHg) 79.6±7.4 77.4±8.3 0.110 76.0±9.4 76.5±7.8 0.440
HR (BPM) 78.1±13.5 78.4±17.1 0.876 79.9±20.1 77.1±16.3 0.763
LAD (mm) 35.4±7.5 34.5±5.1 0.409 33.4±3.9 34.2±5.1 0.069
EF (%) 62.1±5.1 63.4±5.3 0.160 64.2±5.3 63.1±6.0 0.201

LAD: Left atrial diameter; BMI: Body Mass Index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HR: Hear Rate; EF: Ejection fraction.

Discussion

In the present study, we found the single nucleotide polymorphism rs3741930 locus in KCNA5 gene was related to the risk of IAF; the population carrying C allele was more susceptible to IAF; the polymorphic loci, rs3741930 and rs1056468, were correlated with the BMI of IAF patients.

With advanced progression in molecular genetics, the researchers found that IAF may be a “molecular channel disease” [27]. While further studies found that KCNA5 mutations were closely associated with IAF [28,29]. In 1993, Phromchotikul et al [30], used multiple-region correlation analysis to position four molecular markers of KCNA5 gene. KCNA5 gene-encoded Kv1.5 potassium channel is a subtype of Kvl potassium channel. The channel consists of αand β subunits; four identical αsubunits form a homologous tetramer, forming the pore region and voltage-sensitive area of Kv1.5 channel complex. Each α subunit contains six transmembrane protein molecule areas (S1 to S6), respectively, constituting the subjects of voltage-gated channels, N and C-terminal subunit. β play a supporting role, maintaining the stability of Kvl.5 channel as a chaperone together with associated membrane protein [31].

KCNA5 gene is specifically expressed in atrial myocytes, coding the pore region of Kv1.5 potassium channel; the channel is the molecular basis of Ikur, playing an important role in action potential duration and effective refractory period of atrial muscle [32]. It helps stabilize cardiac cell electrophysiological activity in sympathetic nervous excitements, and it is down-regulated during AF [33,34]. In 2006, Olson et al [28] conducted the KCNA5 gene screening in 154 cases of American IAF patients. It had been found in one patient with early-onset FAF that Kv1.5 channel function-loss caused by E375X mutation was an important factor to induce IAF, and it had been confirmed in animal models. Then Yang et al [29] have found that function-loss mutations in T527M, A576V, and E610K of KCNA5 gene can reduce IKur current, thereby inducing IAF.

At present, some studies have shown that mutations of SNP loci located on KCNA5 gene may affect the function and expression of Kv1.5 channel [35]. In order to determine whether KCNA5 gene SNP is associated with IAF in Chinese population, this study included 282 cases of IAF patients and 300 cases of age and sex-matched healthy individuals to compare their KCNA5 gene SNP distribution s. The results show that SNP rs3741930 of KCNA5 gene was correlated with IAF, and C allele frequency was significantly higher compared with control group. This is the first report by far on the correlation between KCNA5 gene SNP rs3741930 and IAF in Chinese population. Rs3741930 is located in the 5’-UTR region of KCNA5 gene, involved in composing some splicing enhancer sequences. The single nucleotide polymorphism C>T of this locus might affect the expression of KCNA5 gene, and impair the structure and function of human atrial myocyte Kv1.5 potassium ion channel, resulting in changes in Ikur current, the action potential duration and effective refractory phase, and thus leading to AF susceptibility.

In addition, we also found there were significant differences in BMI between IAF patients with rs3741930 or rs1056468 locus mutation and those without gene mutations. Sascha Dublin et al [36] conducted a study on 425 new-onset AF patients and 707 normal individuals and found that with each unit increase in BMI, the probability of occurrence of AF will be increased by 3%; the occurrence and development of AF had a significant association with BMI. Up to date, there is no literature reporting the correlation between KCNA5 gene and BMI; the specific mechanism is unclear and needs further study.

In conclusion, we found that the SNP rs3741930 of KCNA5 gene was related with IAF pathogenesis; patients carrying C allele were more susceptible to IAF. Meanwhile both rs3741930 and rs1056468 were associated with the BMI of IAF patients. However, our results should be confirmed by large-sample and multi-center studies in future.

Disclosure of conflict of interest

None.

References

  • 1.European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH ESC Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Europace. 2010;12:1360–420. doi: 10.1093/europace/euq350. [DOI] [PubMed] [Google Scholar]
  • 2.Zhou ZQ, Hu DY, Chen J, Zhang RH, Li KB, Zhao XL. An epidemiological survey of atrial fibrillation in China. Zhonghua Nei Ke Za Zhi. 2004;43:491–4. [PubMed] [Google Scholar]
  • 3.Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–4. [PubMed] [Google Scholar]
  • 4.Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018–22. doi: 10.1056/NEJM198204293061703. [DOI] [PubMed] [Google Scholar]
  • 5.Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96:2455–61. doi: 10.1161/01.cir.96.7.2455. [DOI] [PubMed] [Google Scholar]
  • 6.Sankaranarayanan R, Kirkwood G, Dibb K, Garratt CJ. Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review. Cardiol Res Pract. 2013;2013:976976. doi: 10.1155/2013/976976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Weijs B, Schotten U, Crijns HJ. Pathophysiology of idiopathic atrial fibrillation-prognostic and treatment implications. Curr Pharm Des. 2015;21:551–72. doi: 10.2174/1381612820666140825150057. [DOI] [PubMed] [Google Scholar]
  • 8.Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, Groenewegen WA, Hauer RN. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res. 2004;95:e29–33. doi: 10.1161/01.RES.0000141134.64811.0a. [DOI] [PubMed] [Google Scholar]
  • 9.Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920–5. doi: 10.1161/01.CIR.0000072767.89944.6E. [DOI] [PubMed] [Google Scholar]
  • 10.Arnar DO, Thorvaldsson S, Manolio TA, Thorgeirsson G, Kristjansson K, Hakonarson H, Stefansson K. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J. 2006;27:708–12. doi: 10.1093/eurheartj/ehi727. [DOI] [PubMed] [Google Scholar]
  • 11.Ellinor PT, Yoerger DM, Ruskin JN, MacRae CA. Familial aggregation in lone atrial fibrillation. Hum Genet. 2005;118:179–84. doi: 10.1007/s00439-005-0034-8. [DOI] [PubMed] [Google Scholar]
  • 12.Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science. 2003;299:251–4. doi: 10.1126/science.1077771. [DOI] [PubMed] [Google Scholar]
  • 13.Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R, Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J, Chen Y. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet. 2004;75:899–905. doi: 10.1086/425342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Otway R, Vandenberg JI, Guo G, Varghese A, Castro ML, Liu J, Zhao J, Bursill JA, Wyse KR, Crotty H, Baddeley O, Walker B, Kuchar D, Thorburn C, Fatkin D. Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? J Am Coll Cardiol. 2007;49:578–86. doi: 10.1016/j.jacc.2006.09.044. [DOI] [PubMed] [Google Scholar]
  • 15.Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med. 1997;336:905–11. doi: 10.1056/NEJM199703273361302. [DOI] [PubMed] [Google Scholar]
  • 16.Xia M, Jin Q, Bendahhou S, He Y, Larroque MM, Chen Y, Zhou Q, Yang Y, Liu Y, Liu B, Zhu Q, Zhou Y, Lin J, Liang B, Li L, Dong X, Pan Z, Wang R, Wan H, Qiu W, Xu W, Eurlings P, Barhanin J, Chen Y. A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun. 2005;332:1012–9. doi: 10.1016/j.bbrc.2005.05.054. [DOI] [PubMed] [Google Scholar]
  • 17.Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol. 2005;16:394–6. doi: 10.1046/j.1540-8167.2005.40621.x. [DOI] [PubMed] [Google Scholar]
  • 18.Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, Sinner MF, de Bakker PI, Mueller M, Lubitz SA, Fox E, Darbar D, Smith NL, Smith JD, Schnabel RB, Soliman EZ, Rice KM, Van Wagoner DR, Beckmann BM, van Noord C, Wang K, Ehret GB, Rotter JI, Hazen SL, Steinbeck G, Smith AV, Launer LJ, Harris TB, Makino S, Nelis M, Milan DJ, Perz S, Esko T, Köttgen A, Moebus S, Newton-Cheh C, Li M, Möhlenkamp S, Wang TJ, Kao WH, Vasan RS, Nöthen MM, MacRae CA, Stricker BH, Hofman A, Uitterlinden AG, Levy D, Boerwinkle E, Metspalu A, Topol EJ, Chakravarti A, Gudnason V, Psaty BM, Roden DM, Meitinger T, Wichmann HE, Witteman JC, Barnard J, Arking DE, Benjamin EJ, Heckbert SR, Kääb S. Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet. 2010;42:240–4. doi: 10.1038/ng.537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett JC Jr, Olson TM. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med. 2008;359:158–65. doi: 10.1056/NEJMoa0706300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Makiyama T, Akao M, Shizuta S, Doi T, Nishiyama K, Oka Y, Ohno S, Nishio Y, Tsuji K, Itoh H, Kimura T, Kita T, Horie M. A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. J Am Coll Cardiol. 2008;52:1326–34. doi: 10.1016/j.jacc.2008.07.013. [DOI] [PubMed] [Google Scholar]
  • 21.Huang M, Gai X, Yang X, Hou J, Lan X, Zheng W, Chen F, He J. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. Clin Chem Lab Med. 2009;47:32–7. doi: 10.1515/CCLM.2009.023. [DOI] [PubMed] [Google Scholar]
  • 22.Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol. 2008;102:326–9. doi: 10.1016/j.amjcard.2008.03.063. [DOI] [PubMed] [Google Scholar]
  • 23.Mays DJ, Foose JM, Philipson LH, Tamkun MM. Localization of the Kv1.5 K+channel protein in explanted cardiac tissue. J Clin Invest. 1995;96:282–92. doi: 10.1172/JCI118032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Feng J, Wible B, Li GR, Wang Z, Nattel S. Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes. Circ Res. 1997;80:572–9. doi: 10.1161/01.res.80.4.572. [DOI] [PubMed] [Google Scholar]
  • 25.Dieudé P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E, Riemekasten G, Diot E, Hunzelmann N, Sibilia J, Tiev K, Mouthon L, Cracowski JL, Carpentier PH, Distler J, Amoura Z, Tarner I, Avouac J, Meyer O, Kahan A, Boileau C, Allanore Y. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum. 2009;60:3447–54. doi: 10.1002/art.24885. [DOI] [PubMed] [Google Scholar]
  • 26.Dieudé P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski JL, Carpentier PH, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore Y. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum. 2009;60:225–33. doi: 10.1002/art.24183. [DOI] [PubMed] [Google Scholar]
  • 27.Dai DZ, Yu F. Ion channelopathy and hyperphosphorylation contributing to cardiac arrhythmias. Acta Pharmacol Sin. 2005;26:918–25. doi: 10.1111/j.1745-7254.2005.00134.x. [DOI] [PubMed] [Google Scholar]
  • 28.Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet. 2006;15:2185–91. doi: 10.1093/hmg/ddl143. [DOI] [PubMed] [Google Scholar]
  • 29.Yang Y, Li J, Lin X, Yang Y, Hong K, Wang L, Liu J, Li L, Yan D, Liang D, Xiao J, Jin H, Wu J, Zhang Y, Chen YH. Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet. 2009;54:277–83. doi: 10.1038/jhg.2009.26. [DOI] [PubMed] [Google Scholar]
  • 30.Phromchotikul T, Browne DL, Curran ME, Keating MT, Litt M. Dinucleotide repeat polymorphism at the KCNA5 locus. Hum Mol Genet. 1993;2:1512. doi: 10.1093/hmg/2.9.1512-a. [DOI] [PubMed] [Google Scholar]
  • 31.Coetzee WA, Amarillo Y, Chiu J, Chow A, Lau D, McCormack T, Moreno H, Nadal MS, Ozaita A, Pountney D, Saganich M, Vega-Saenz de Miera E, Rudy B. Molecular diversity of K+channels. Ann N Y Acad Sci. 1999;868:233–85. doi: 10.1111/j.1749-6632.1999.tb11293.x. [DOI] [PubMed] [Google Scholar]
  • 32.Poparic I, Schreibmayer W, Schoser B, Desoye G, Gorischek A, Miedl H, Hochmeister S, Binder J, Quasthoff S, Wagner K, Windpassinger C, Malle E. Four and a half LIM protein 1C (FHL1C): a binding partner for voltage-gated potassium channel K (v1.5) PLoS One. 2011;6:e26524. doi: 10.1371/journal.pone.0026524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Li GR, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic modulation of ultrarapid delayed rectifier K+current in human atrial myocytes. Circ Res. 1996;78:903–15. doi: 10.1161/01.res.78.5.903. [DOI] [PubMed] [Google Scholar]
  • 34.Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 1997;80:772–81. doi: 10.1161/01.res.80.6.772. [DOI] [PubMed] [Google Scholar]
  • 35.Remillard CV, Tigno DD, Platoshyn O, Burg ED, Brevnova EE, Conger D, Nicholson A, Rana BK, Channick RN, Rubin LJ, O’connor DT, Yuan JX. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension. Am J Physiol Cell Physiol. 2007;292:C1837–53. doi: 10.1152/ajpcell.00405.2006. [DOI] [PubMed] [Google Scholar]
  • 36.Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, Smith NL, Heckbert SR. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166:2322–8. doi: 10.1001/archinte.166.21.2322. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Medicine are provided here courtesy of e-Century Publishing Corporation

RESOURCES